Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.26 +0.44 (+11.65%)
As of: Oct 21, 2026 · 3:45 PM EDT

Adial Pharmaceuticals (ADIL) Capital Expenditures (2021)

Updated

Adial Pharmaceuticals' Capital Expenditures was $64,605 in FY2021.

Analysis

Adial Pharmaceuticals (ADIL) Capital Expenditures (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Adial Pharmaceuticals 19.71 Mn -24.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 33,730.00
Mar 31, 2021 30,875.00
API Access

Adial Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ADIL&period=max&api_key=YOUR_API_KEY